Seòmar agus comataidhean

Following announcement of the additional £40m in targeted voids and acquisitions in my statement to Parliament on 2 September, the 2025-26 budget for AHSP is £807.745m and represents an increase of £251.883m when compared to the original published 2024-25 budget of £555.862m. The 2025–26 budget not only restores but exceeds the 2023–24 budget.

Due to concerns over patient confidentiality a single length of delay figure cannot be provided.

A delayed discharge occurs when a hospital patient who is clinically ready for discharge from inpatient hospital care continues to occupy a hospital bed beyond the date they are ready for discharge. Official Statistics on delayed discharges in NHS Scotland are available here: About this release - Delayed discharges in NHSScotland monthly - Figures for July 2025 - Delayed discharges in NHSScotland monthly - Publications - Public Health Scotland. This publication includes the number of people delayed at each monthly census point by length of delay at census point. A person’s length of delay at census is calculated as the time from their latest ready for discharge date to the monthly census point.

Following a full submission of doxylamine succinate and pyridoxine hydrochloride (Xonvea®), for the treatment of nausea and vomiting in pregnancy (NVP), for women who do not respond to conservative management, the SMC | Scottish Medicines Consortium (SMC) published not recommended advice found here: doxylamine succinate and pyridoxine hydrochloride (Xonvea) in May 2019. The marketing authorisation holder did not present a sufficiently robust clinical or economic analysis to gain acceptance by the SMC. The SMC would welcome a resubmission at any time.

Where licensed medicines, such as Xonvea®, are not routinely available on the NHS in Scotland, doctors can use the PACS Tier Two system to request access on a case-by-case basis. The cost of the medicine is not a decision-making criterion.

I refer the member to the answer to question S6W-38163 on 17 June 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

Our revised Pathway of Maternity Care clinical guidance and schedule, published on 6 February 2025, sets out the core care that all women and babies should receive under a whole-person, individualised care approach which takes account of their specific circumstances. We remain committed to implementation of continuity of carer by mid-2026, under The Best Start, as part of our Programme for Government 2025-26, recognising that the evidence tells us that this approach will be of greatest benefit to women and families from minoritised and marginalised communities.

On 6 February 2025, we published our Tackling Racialised Health Inequalities in Maternity Care Action Plan, which outlines our next steps for both local and national action. This is supplemented by our Interpretation Toolkits, designed to support staff to deliver maternity care where women require the use of an interpreter. Our data and evidence resource provides NHS Boards with an overview of the sources available to support local improvement activity.

We have asked all 22 NHS Boards to develop and deliver against anti-racism plans, covering workforce and service delivery. Planning guidance issued to NHS Boards in September 2024 and identifies perinatal care as an early priority for action.

The Scottish Government Sexual Health and Blood Borne Virus Action Plan was launched in 2023 and places a large focus on how to ensure everyone who needs it can access good sexual and reproductive health. LGBT Youth Scotland, Scotland’s national charity for LGBTI+ young people, was awarded multi-year funding to support LGBTI+ young people. The projects aims to ensure that LGBTI+ young people have improved awareness around sexual health and wellbeing, and increased access to this information to address inequity in sexual health care.

Since taking up this role in June I have not had a meeting with the Interim Chief Executive of NHS Grampian. I attended the Collaborative Response and Assurance Group on 11 August 2025 which the Chief Officer of Health and Social Care Moray attended.

The Scottish Government recognises the challenges people with Ehlers-Danlos syndromes (EDS) face in obtaining diagnosis and care. Diagnosis usually begins with a GP referral and may involve rheumatologists, geneticists, and other specialists. Hypermobile EDS (hEDS) is diagnosed clinically, while genetic testing is available for rarer forms of EDS.

EDS can affect people in different ways. While there is no cure for EDS, treatment and support focus on helping people manage symptoms and prevent complications. NHS Scotland provides multidisciplinary care through hospitals in Edinburgh, Glasgow, and Aberdeen, and Scottish patients can access more specialist EDS services in England via cross-border referrals if clinically indicated.

I last met with the Interim Chief Executive of NHS Grampian on 7 February 2025 and met with the Chief Officer of Health and Social Care Moray on 8th January 2025.

We know many people are still waiting too long and this is not good enough. We are determined to do more and our Budget will provide a record £21.7 billion for health and social care, with more than £110 million allocated to health boards, including over £6.6 million for NHS Lanarkshire, to help tackle the longest waits for appointments and procedures.

The funding has been assigned to specialty areas for the year ahead where it can have the greatest impact against the longest waits – this includes £25 million for trauma and orthopaedics, £21 million for imaging, £14 million for cancer treatment and more than £12 million for ophthalmology.

It will also support delivery of planned care for patients across Scotland, to increase capacity and address backlogs of treatment as we work towards achieving the 18 weeks Referral to Treatment (RTT) standard.

The Scottish Government is committed to recovering benefit overpayments wherever it is considered economic and reasonable to do so in line with the principles set out in the Scottish Public Finance Manual.

Social Security Scotland has established a Debt Management Service to oversee the recovery of overpayments, ensuring that recovered funds are redistributed in line with Scottish public spending priorities. Recovery processes are carried out with respect for clients’ dignity.

While internal systems are in place to track and prevent overpayments, detailed statistics—such as the number of overpayments or the age profile of debts—are not routinely published. As such, we are unable to provide further breakdowns.